BRIEF-Skydance-Paramount Merger Agreement Extended For 90 Days

BRIEF-Skydance-Paramount Merger Agreement Extended For 90 Days - Variety

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Skydance-Paramount Merger Agreement Extended For 90 Days - Variety

Apr 7, 2025 2:27 PM

April 7 (Reuters) -

* SKYDANCE-PARAMOUNT MERGER AGREEMENT, WHICH IS STILL

PENDING FCC

APPROVAL, EXTENDED FOR 90 DAYS - VARIETY

Source text: tinyurl.com/5dvfrt6j

Further company coverage:

Previous page： Canacol Energy Posts 80% Increase in Q3 Net lncome Next page： Palantir Technologies, FTAI Aviation Partner on Aircraft Maintenance Technology

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Canacol Energy Posts 80% Increase in Q3 Net lncome

Nov 17, 2025

07:52 AM EST, 11/17/2025 (MT Newswires) -- Colombia-focused Canacol Energy ( CNNEF ) reported Monday an 80% increase in net income for the third quarter. The natural gas exploration and production company booked a net income and comprehensive income of US$18.7 million, or $0.55 per share, in the three months ended Sept. 30, rising from $10.3 million, or $0.30 per...

Palantir Technologies, FTAI Aviation Partner on Aircraft Maintenance Technology

Nov 17, 2025

07:50 AM EST, 11/17/2025 (MT Newswires) -- Palantir Technologies ( PLTR ) and FTAI Aviation ( FTAI ) said Monday it has formed a multi-year partnership. Financial terms were not disclosed. Under the deal, Palantir's ( PLTR ) AI will be incorporated into FTAI's aircraft maintenance operations worldwide . FTAI shares were up 3% in recent premarket activity. ...

Novo Nordisk rolls out $349 Wegovy cash price ahead of plan

Nov 17, 2025

* Novo Nordisk cuts Wegovy price to $349 for cash payers early * Novo launches $199 deal for Wegovy, Ozempic lowest doses * GoodRx will launch a weight-loss telehealth service for $39 a month By Patrick Wingrove Nov 17 (Reuters) - Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to...

Biogen Says EU Committee Recommends Approval of High Dose Nusinersen Regimen

Nov 17, 2025

07:51 AM EST, 11/17/2025 (MT Newswires) -- Biogen (BIIB) said Monday the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of a high dose regimen of nusinersen for the treatment of 5q spinal muscular atrophy. The CHMP's positive opinion will now be reviewed by the European Commission, with a final decision expected in January, the...